Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 11 to 55 Years of Age in Korea

NCT01274897 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT01274897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01274897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 11 to 55 Years of Age in Korea
Lead sponsor
Novartis Vaccines
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2010
Completion date
March 31, 2011
Enrollment
450 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal disease, meningococcal meningitis